Marbofloxacin (Marbofloxacin) - Uses, Dosage and Side Effects

Marbofloxacin for dogs and cats is a third-generation fluoroquinolone antibiotic. Marbofloxacin is active against a broad range of Gram-negative and Gram-positive bacteria, including many organisms that commonly cause skin, urinary tract, and respiratory infections in dogs and cats. Dogs and cats with recurrent skin infections or urinary tract infections caused by Pseudomonas or Escherichia coli are among those commonly managed with Marbofloxacin.

Marbofloxacin works by stopping bacteria from multiplying. It does this by blocking specific enzymes that bacteria need to copy and repair their DNA. Without this process, the bacteria cannot grow or survive, and the infection gradually clears as the immune system removes the remaining bacteria.

Because marbofloxacin spreads well into different body tissues, it can reach infection sites such as the urinary tract, prostate, skin, and some internal organs. This makes it useful for certain infections where other antibiotics may not penetrate as effectively. However, it is only effective against specific bacteria, so use it only when a vet suspects or confirms the infection will respond to this medicine.

In cats, marbofloxacin works the same way: it blocks bacterial DNA replication, stopping susceptible bacteria from multiplying and leading to their elimination.

Vets may use it for selected bacterial infections in cats, including those affecting the skin, soft tissues, or respiratory system, when testing or clinical judgment shows that a fluoroquinolone antibiotic is appropriate.

Use marbofloxacin only when necessary and based on a proper diagnosis, because unnecessary use can reduce its effectiveness over time due to antibiotic resistance and may also expose cats to avoidable side effects.

Marbofloxacin dosage for dogs is weight-based and administered orally once daily. Marbofloxacin is typically prescribed for 5 to 30 days in dogs, depending on the infection type and severity. Deep pyoderma and bone infections generally require longer courses than uncomplicated urinary tract infections. You can give tablets with or without food. Complete the full prescribed course even if clinical improvement is apparent before the course ends, to prevent bacterial recurrence and resistance development.

Fluoroquinolones should be used with caution in growing dogs, as this antibiotic class has been associated with cartilage damage in developing joints. Marbofloxacin is generally avoided in dogs under 12 months of age, or under 18 months in large and giant breeds.

Small dogs receive a lower total dose based on body weight. Accurate weight measurement ensures you select the correct tablet strength. Marbofloxacin is most clinically useful for small breeds with recurrent urinary tract infections caused by resistant organisms.

Weight-based once-daily dosing applies consistently. Culture and sensitivity testing before prescribing marbofloxacin in medium dogs with recurrent infections reduces the risk of unnecessary selection for resistance.

Large dogs require higher total doses based on body weight. Dogs with deep pyoderma, where bacterial infection penetrates the dermis and subcutaneous tissue, may require 3 to 6 weeks of treatment. Follow-up skin evaluation is important to confirm resolution before stopping antibiotic therapy.

Marbofloxacin dosage for cats is weight-based and given orally once daily. Cats require careful dose calculation because high fluoroquinolone concentrations carry a risk of retinal toxicity in this species, particularly at doses above the recommended therapeutic range. Your vet will prescribe the correct dose and duration based on the infection type and the cat's body weight. Never exceed the prescribed dose or extend the course without veterinary reassessment.

Kittens should not receive marbofloxacin without specialist assessment due to the risk of cartilage toxicity in developing joints and greater sensitivity to fluoroquinolone effects. If prescribed, use precise weight-based dosing and closely monitor for signs of lameness or vision changes.

Side effects are uncommon at recommended doses but require monitoring, particularly with long courses.

Cats may experience vomiting, reduced appetite, and lethargy. The most clinically significant risk in cats is retinal toxicity from excessive fluoroquinolone exposure, which can cause sudden blindness. Mydriasis (abnormally dilated pupils), reduced visual response, or apparent disorientation in a cat on marbofloxacin require immediate veterinary ophthalmological assessment.

Marbofloxacin overdose in dogs may cause severe vomiting, tremors, disorientation, seizures, and cardiovascular changes. At toxic doses, fluoroquinolones stimulate the central nervous system, making neurological signs the primary concern. Seek an immediate canine vet checkup if an overdose is suspected.

Cats are more susceptible to retinal toxicity and neurological effects from fluoroquinolone overdose than dogs. Sudden blindness, seizures, severe lethargy, and disorientation may occur. Seek emergency veterinary care at the nearest cat hospital immediately. Retinal damage from fluoroquinolone toxicity in cats may be permanent if not identified and managed promptly.

Store marbofloxacin tablets at room temperature away from direct sunlight and moisture. Keep in the original packaging with the lid tightly sealed between doses. Store injectable solutions according to the product instructions and use them within the recommended period after opening. Store out of reach of children and pets. Do not use after the expiry date.

Contact your vet if your pet develops persistent vomiting, tremors, disorientation, lameness, sudden visual changes, or no clinical improvement after 3 to 5 days of treatment. Retinal signs in cats require immediate ophthalmological assessment. Worsening infection despite antibiotic therapy may indicate resistant bacteria, an incorrect diagnosis, or an abscess requiring surgical drainage alongside antibiotic treatment.

Marbofloxacin for dogs and cats is an effective third-generation fluoroquinolone antibiotic for managing bacterial infections caused by susceptible organisms. Responsible prescribing based on culture sensitivity results, accurate weight-based dosing, and completing the full course are essential to ensure effective treatment and minimise fluoroquinolone resistance in veterinary patients.